Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.30 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.30 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 2/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17432184 | 0.94 | CYP2A6 (0.35) | CYP2A6DYRK1AALDH1A1CA12CA2 | |
| SCHEMBL15040947 | 0.94 | CYP2A6 (0.37) | CYP2A6DYRK1AALDH1A1CA12CA2 | |
| SCHEMBL18386539 | 0.89 | CYP2A6 (0.33) | CYP2A6DYRK1AALDH1A1 | |
| SCHEMBL18177620 | 0.89 | CYP2A6 (0.33) | CYP2A6DYRK1AALDH1A1 | |
| SCHEMBL12277651 | 0.86 | CYP2A6 (0.31) | CYP2A6ALDH1A1 | |
| SCHEMBL19423246 | 0.86 | CYP2A6 (0.31) | CYP2A6ALDH1A1 | |
| SCHEMBL18965563 | 0.85 | CYP2A6 (0.33) | CYP2A6DYRK1AALDH1A1 | |
| SCHEMBL19222466 | 0.85 | CYP2A6 (0.33) | CYP2A6DYRK1AALDH1A1 | |
| SCHEMBL12277677 | 0.83 | CYP2A6 (0.31) | CYP2A6ALDH1A1 | |
| SCHEMBL4420009 | 0.82 | ALDH1A1 (0.39) | CYP2A6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7351266-B2 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2008-04-01 | — | — | US | claimed |
| US-20050193504-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | PROCTER & GAMBLE COMPANY, THE | 2005-09-08 | — | — | US | claimed |
| EP-3481834-B1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2023-10-18 | — | — | EP | disclosed |
| EP-2828903-B1 | OPTOELECTRONIC DEVICES COMPRISING POLYMERIC BLENDS | RAYNERGY TEK INC (TW) | 2017-11-01 | — | — | EP | disclosed |
| US-9312501-B2 | Semiconducting compounds and optoelectronic devices incorporating same | POLYERA CORPORATION (US) | 2016-04-12 | — | — | US | disclosed |
| US-9312492-B2 | Polymeric blends and related optoelectronic devices | RAYNERGY TEK INC. (TW) | 2016-04-12 | — | — | US | disclosed |
| US-9312492-B2 | Polymeric blends and related optoelectronic devices | RAYNERGY TEK INC. (TW) | 2016-04-12 | — | — | US | disclosed |
| US-9312501-B2 | Semiconducting compounds and optoelectronic devices incorporating same | POLYERA CORPORATION (US) | 2016-04-12 | — | — | US | disclosed |
| US-20160072070-A1 | POLYMERIC BLENDS AND RELATED OPTOELECTRONIC DEVICES | POLYERA CORPORATION | 2016-03-10 | — | — | US | disclosed |
| US-20160072070-A1 | POLYMERIC BLENDS AND RELATED OPTOELECTRONIC DEVICES | POLYERA CORPORATION | 2016-03-10 | — | — | US | disclosed |
| US-20150171332-A1 | POLYMERIC BLENDS AND RELATED OPTOELECTRONIC DEVICES | RAYNERGY TEK INC. (TW) | 2015-06-18 | — | — | US | disclosed |
| US-20130247990-A1 | Conjugated Polymers and Their Use in Optoelectronic Devices | RAYNERGY TEK INC. (TW) | 2013-09-26 | — | — | US | disclosed |
| US-20130247992-A1 | Polymeric Blends and Related Optoelectronic Devices | RAYNERGY TEK INC. (TW) | 2013-09-26 | — | — | US | disclosed |
| EP-1720615-B1 | COSMETIC HAIR DYEING COMPOSITIONS CONTAINING THEM AND USE THEREOF | PROCTER & GAMBLE (US) | 2009-12-30 | — | — | EP | disclosed |
| US-7468080-B2 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2008-12-23 | — | — | US | disclosed |
| US-20080134450-A1 | Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof | WELLA OPERATIONS US, LLC | 2008-06-12 | — | — | US | disclosed |
| US-7351266-B2 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2008-04-01 | — | — | US | disclosed |
| EP-1720615-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF | The Procter and Gamble Company (US) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005087187-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2005-09-22 | — | — | WO | disclosed |
| US-20050193504-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | PROCTER & GAMBLE COMPANY, THE | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050193504-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | KRT18, CKMT1A; CKMT1B, KRTCAP2 | CYP2A6 405/4885DYRK1A 2218/4885ALDH1A1 657/4885 |
| US-20080134450-A1 | Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof | KRT18, CKMT1A; CKMT1B, KRTCAP2 | CYP2A6 405/4885DYRK1A 2218/4885ALDH1A1 657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.